Compare Stocks: TECH and INMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INMD InMode	$14.93 -0.7%	$14.93	$12.72 ▼ $16.74	$863.94M	1.89	447,745 shs	318,990 shs
TECH Bio-Techne	$72.38 +0.1%	$70.28	$43.19 ▼ $72.62	$11.34B	1.28	3.24 million shs	1.39 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INMD InMode	-0.67%	-0.73%	-2.93%	+6.26%	+0.34%
TECH Bio-Techne	+0.07%	-0.14%	+1.06%	+42.37%	+27.45%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INMD InMode	$14.93 -0.7%	$14.93	$12.72 ▼ $16.74	$863.94M	1.89	447,745 shs	318,990 shs
TECH Bio-Techne	$72.38 +0.1%	$70.28	$43.19 ▼ $72.62	$11.34B	1.28	3.24 million shs	1.39 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INMD InMode	-0.67%	-0.73%	-2.93%	+6.26%	+0.34%
TECH Bio-Techne	+0.07%	-0.14%	+1.06%	+42.37%	+27.45%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INMD InMode	2.00	Hold	$16.00	7.17% Upside
TECH Bio-Techne	2.12	Hold	$68.92	-4.78% Downside

Current Analyst Ratings Breakdown

Latest TECH and INMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	TECH Bio-Techne	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/25/2026	TECH Bio-Techne	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/19/2026	TECH Bio-Techne	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
8/13/2026	TECH Bio-Techne	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$62.00 ➝ $73.00
8/6/2026	INMD InMode	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/4/2026	TECH Bio-Techne	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C-)
7/9/2026	TECH Bio-Techne	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$62.00 ➝ $73.00
7/6/2026	TECH Bio-Techne	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
6/30/2026	TECH Bio-Techne	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
6/29/2026	TECH Bio-Techne	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$65.00 ➝ $73.00
6/26/2026	TECH Bio-Techne	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$70.00 ➝ $73.00

(Data available from 8/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INMD InMode	$370.49M	2.32	$1.48 per share	10.07	$10.94 per share	1.36
TECH Bio-Techne	$1.22B	9.34	$2.35 per share	30.81	$13.44 per share	5.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INMD InMode	$93.83M	$1.23	12.14	N/A	N/A	20.69%	11.99%	10.60%	10/28/2026 (Estimated)
TECH Bio-Techne	$181.86M	$1.15	62.94	36.01	8.62	14.97%	13.23%	10.61%	11/4/2026 (Estimated)

Latest TECH and INMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/12/2026	Q4 2026	TECH Bio-Techne	$0.5190	$0.52	+$0.0010	$0.35	$314.63 million	$321.19 million
8/5/2026	Q2 2026	INMD InMode	$0.3460	$0.35	+$0.0040	$0.29	$94.89 million	$95.59 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
INMD InMode	N/A	N/A	N/A	N/A	N/A
TECH Bio-Techne	$0.32	0.44%	N/A	27.83%	N/A

Latest TECH and INMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	TECH Bio-Techne	quarterly	$0.65	0.44%	8/24/2026	8/24/2026	9/4/2026
8/12/2026	TECH Bio-Techne	quarterly	$0.08	0.44%	8/17/2026	8/17/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INMD InMode	N/A	8.18	7.28
TECH Bio-Techne	0.09	4.55	3.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INMD InMode	68.04%
TECH Bio-Techne	98.95%

Insider Ownership

Company	Insider Ownership
INMD InMode	6.92%
TECH Bio-Techne	1.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INMD InMode	480	57.48 million	53.50 million	Optionable
TECH Bio-Techne	3,100	156.82 million	154.76 million	Optionable

TECH and INMD Headlines

Recent News About These Companies

Bio-Techne (NASDAQ:TECH) Rating Increased to Hold at Zacks Research

17 minutes ago | marketbeat.com

Pentwater Capital Management LP Takes Position in Bio-Techne Corp $TECH

45 minutes ago | marketbeat.com

Man Group plc Takes Position in Bio-Techne Corp $TECH

1 hour ago | marketbeat.com

American Capital Management Inc. Buys Shares of 973,789 Bio-Techne Corp $TECH

3 hours ago | marketbeat.com

Sculptor Capital LP Makes New $24.73 Million Investment in Bio-Techne Corp $TECH

August 26 at 6:32 AM | marketbeat.com

21,541 Shares in Bio-Techne Corp $TECH Acquired by Roberts Glore & Co. Inc. IL

August 26 at 6:16 AM | marketbeat.com

Kintayl Capital LP Buys Shares of 22,689 Bio-Techne Corp $TECH

August 26 at 6:08 AM | marketbeat.com

Bio-Techne’s Restrictive Merger Terms and Heavy Termination Fee Threaten Competitive Bidding and Future Deal Leverage

August 26 at 2:11 AM | tipranks.com

Commerce Bank Acquires New Position in Bio-Techne Corp $TECH

August 25 at 4:07 AM | marketbeat.com

Bank of New York Mellon Corp Invests $90.31 Million in Bio-Techne Corp $TECH

August 25 at 3:21 AM | marketbeat.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH)

August 24 at 1:56 PM | globenewswire.com

P Schoenfeld Asset Management LP Makes New Investment in Bio-Techne Corp $TECH

August 24 at 6:32 AM | marketbeat.com

PEAK6 LLC Buys New Shares in Bio-Techne Corp $TECH

August 24 at 6:08 AM | marketbeat.com

Quantbot Technologies LP Takes Position in Bio-Techne Corp $TECH

August 24 at 5:44 AM | marketbeat.com

Callan Family Office LLC Buys New Position in Bio-Techne Corp $TECH

August 24 at 3:59 AM | marketbeat.com

Athos Capital Ltd Buys New Stake in Bio-Techne Corp $TECH

August 24 at 3:11 AM | marketbeat.com

Landscape Capital Management L.L.C. Invests $1.82 Million in Bio-Techne Corp $TECH

August 23, 2026 | marketbeat.com

B. Metzler seel. Sohn & Co. AG Invests $2.20 Million in Bio-Techne Corp $TECH

August 23, 2026 | marketbeat.com

TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders

August 22, 2026 | businesswire.com

Ceredex Value Advisors LLC Invests $8.49 Million in Bio-Techne Corp $TECH

August 22, 2026 | marketbeat.com

Brokerages Set Bio-Techne Corp (NASDAQ:TECH) PT at $68.92

August 22, 2026 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TECH and INMD Company Descriptions

InMode NASDAQ:INMD

$14.93 -0.10 (-0.67%)

Closing price 08/26/2026 04:00 PM Eastern

Extended Trading

$14.69 -0.24 (-1.63%)

As of 05:37 AM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Bio-Techne NASDAQ:TECH

$72.38 +0.05 (+0.07%)

Closing price 08/26/2026 04:00 PM Eastern

Extended Trading

$72.17 -0.21 (-0.29%)

As of 06:37 AM Eastern

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TECH and INMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TECH and INMD Earnings

Compare Dividends

Latest TECH and INMD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TECH and INMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TECH and INMD Company Descriptions

InMode NASDAQ:INMD

Bio-Techne NASDAQ:TECH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TECH and INMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TECH and INMD Earnings

Compare Dividends

Latest TECH and INMD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TECH and INMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TECH and INMD Company Descriptions

InMode NASDAQ:INMD

Bio-Techne NASDAQ:TECH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools